Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.37 |
| ▸ | SLC40A1 | Q9NP59 | 8/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CKS1B | P61024 | 1/20 | 0.34 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CCR4 | P51679 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27118142 | 0.87 | SLC40A1 (0.41) | PIK3CASLC40A1GLO1KMT2AMITF | |
| SCHEMBL30846341 | 0.87 | SLC40A1 (0.41) | PIK3CASLC40A1GLO1KMT2AMITF | |
| SCHEMBL27118277 | 0.86 | GAA (0.38) | PIK3CASLC40A1GLO1KMT2AMITF | |
| SCHEMBL27119245 | 0.86 | GAA (0.48) | PIK3CASLC40A1KMT2AALDH1A1LMNA | |
| SCHEMBL30846288 | 0.86 | GAA (0.38) | PIK3CASLC40A1GLO1KMT2AMITF | |
| SCHEMBL30846276 | 0.86 | SLC40A1 (0.40) | PIK3CASLC40A1GLO1KMT2AMITF | |
| SCHEMBL27118195 | 0.86 | SLC40A1 (0.40) | PIK3CASLC40A1GLO1KMT2AMITF | |
| SCHEMBL30846255 | 0.84 | EIF2AK3 (0.48) | PTGES2PIK3CASLC40A1GLO1LMNA | |
| SCHEMBL27119198 | 0.84 | EIF2AK3 (0.48) | PTGES2PIK3CASLC40A1GLO1LMNA | |
| SCHEMBL30846306 | 0.84 | SLC40A1 (0.42) | PIK3CASLC40A1GLO1KMT2AMITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150365-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. | 2024-05-09 | — | — | US | disclosed |
| WO-2024044344-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150365-A1 | PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | MALT1, BCL6, BCL6B | PTGES2 2085/4885PIK3CA 781/4885SLC40A1 816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.